WO2025057087 - SOLID STATE FORMS OF SAMURACICLIB
National phase entry:
Publication Number
WO/2025/057087
Publication Date
20.03.2025
International Application No.
PCT/IB2024/058844
International Filing Date
11.09.2024
Title **
[English]
SOLID STATE FORMS OF SAMURACICLIB
[French]
FORMES À L'ÉTAT SOLIDE DE SAMURACICLIB
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
Inventors
KORDIC, Lorena
Priority Data
63/581,730
11.09.2023
US
63/590,801
17.10.2023
US
63/599,586
16.11.2023
US
63/618,962
09.01.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2385 | |
| EPO | Filing, Examination, Granting | 11234 | |
| Japan | Filing, Examination, Granting | 2338 | |
| South Korea | Filing, Examination, Granting | 2546 | |
| USA | Filing, Examination, Granting | 9140 |
Total:
27,643
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure encompasses solid state forms of Samuraciclib and/or of Samuraciclib salts, in embodiments crystalline polymorphs of Samuraciclib and/or of Samuraciclib salts, processes for preparation thereof, and pharmaceutical compositions thereof.[French]
La présente divulgation concerne des formes à l'état solide de samuraciclib et/ou de sels de samuraciclib, dans des modes de réalisation, des polymorphes cristallins de samuraciclib et/ou de sels de samuraciclib, leurs procédés de préparation et des compositions pharmaceutiques associées.